PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

Saved in:
Bibliographic Details
Published in:Value in health 2012-11, Vol.15 (7), p.A424-A424
Main Authors: Garrido, P, López-Vivanco, G, Rosell, R, Espinós, B, Castro-Gomez, A
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2012.08.2122